Seattle Genetics (SGEN) reported its recent studies about the antibody-drug conjugate and related technology.
Seattle Genetics Shares Gain 1%
Tags
Seattle Genetics (SGEN) reported its recent studies about the antibody-drug conjugate and related technology.